[HTML][HTML] COVID-19 vaccines: Current status and implication for use in Indonesia
Abstract The coronavirus disease 2019 (COVID-19) has inflicted catastrophic damages in
public health, economic and social stability—putting life globally on hold in 2020 and …
public health, economic and social stability—putting life globally on hold in 2020 and …
Safety & effectiveness of COVID-19 vaccines: A narrative review
F Chirico, JAT da Silva, P Tsigaris… - Indian Journal of …, 2022 - journals.lww.com
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use
Authorization by the WHO that can offer some protection to the world's population during the …
Authorization by the WHO that can offer some protection to the world's population during the …
A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
[HTML][HTML] Review of Covid-19 vaccine clinical trials-A puzzle with missing pieces
HF Kwok - International Journal of Biological Sciences, 2021 - ncbi.nlm.nih.gov
A year after the initial outbreak of Covid-19 pandemic, several Phase III clinical trials
investigating vaccine safety and efficacy have been published. These vaccine candidates …
investigating vaccine safety and efficacy have been published. These vaccine candidates …
COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations
Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …
significantly higher than that of the first wave of early 2020. Many countries or regions have …
[HTML][HTML] A review on the advancements in the development of vaccines to combat coronavirus disease 2019
H Onyeaka, ZT Al-Sharify, MY Ghadhban… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), the deadly disease caused by SARS-CoV-
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
[PDF][PDF] COVID-19 vaccination efficacy and safety literature review
Since the emergency of the novel coronavirus disease (COVID-19) that is caused by SARS-
Cov-2 in 2019, researchers have been on the move to find solutions to mitigate the spread of …
Cov-2 in 2019, researchers have been on the move to find solutions to mitigate the spread of …
COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
[HTML][HTML] Safety, tolerability, and immunogenicity of COVID-19 vaccines: a systematic review and meta-analysis
P Yuan, P Ai, Y Liu, Z Ai, Y Wang, W Cao, X Xia… - MedRxiv, 2020 - ncbi.nlm.nih.gov
We aimed to summarize reliable medical evidence by the meta-analysis of all published
clinical trials that investigated the safety, tolerability, and immunogenicity of vaccine …
clinical trials that investigated the safety, tolerability, and immunogenicity of vaccine …